Armistice Capital’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.39M Buy
+1,024,000
New +$3.1M 0.03% 138

Other funds holding PYXS

Armistice Capital's PYXS Position: Q3 2026 in Review

Armistice Capital opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 1,024,000 shares worth $2.39M. The stake represents 0.03% of the portfolio and ranks #138 among its holdings.

83 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • Armistice Capital held 1,024,000 shares of Pyxis Oncology worth $2.39M as of Q3 2026.
  • Pyxis Oncology was a new Armistice Capital position in Q3 2026.
  • Pyxis Oncology made up 0.03% of Armistice Capital's portfolio in Q3 2026, its #138 holding.
  • 83 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.